NO20034235D0 - Ny fremgangsmåte for den industrielle syntese av strontiumranelat og dets hydrater - Google Patents

Ny fremgangsmåte for den industrielle syntese av strontiumranelat og dets hydrater

Info

Publication number
NO20034235D0
NO20034235D0 NO20034235A NO20034235A NO20034235D0 NO 20034235 D0 NO20034235 D0 NO 20034235D0 NO 20034235 A NO20034235 A NO 20034235A NO 20034235 A NO20034235 A NO 20034235A NO 20034235 D0 NO20034235 D0 NO 20034235D0
Authority
NO
Norway
Prior art keywords
hydrates
new method
industrial synthesis
strontium ranelate
ranelate
Prior art date
Application number
NO20034235A
Other languages
English (en)
Other versions
NO328638B1 (no
NO20034235L (no
Inventor
Lucile Vaysse-Ludot
Jean-Pierre Lecouve
Pascal Langlois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20034235D0 publication Critical patent/NO20034235D0/no
Publication of NO20034235L publication Critical patent/NO20034235L/no
Publication of NO328638B1 publication Critical patent/NO328638B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inorganic Insulating Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
NO20034235A 2002-09-24 2003-09-23 Ny fremgangsmate for den industrielle syntese av strontiumranelat og dets hydrater NO328638B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0211763A FR2844795B1 (fr) 2002-09-24 2002-09-24 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Publications (3)

Publication Number Publication Date
NO20034235D0 true NO20034235D0 (no) 2003-09-23
NO20034235L NO20034235L (no) 2004-03-25
NO328638B1 NO328638B1 (no) 2010-04-12

Family

ID=29415189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034235A NO328638B1 (no) 2002-09-24 2003-09-23 Ny fremgangsmate for den industrielle syntese av strontiumranelat og dets hydrater

Country Status (38)

Country Link
US (1) US7214805B2 (no)
EP (1) EP1403266B1 (no)
JP (1) JP4136867B2 (no)
KR (1) KR100551501B1 (no)
CN (1) CN1212321C (no)
AP (1) AP1910A (no)
AR (1) AR041355A1 (no)
AU (2) AU2003282179A1 (no)
BR (1) BR0304213A (no)
CA (1) CA2442878C (no)
CR (1) CR7764A (no)
CY (1) CY1115162T1 (no)
DK (1) DK1403266T3 (no)
EA (1) EA007489B1 (no)
EC (1) ECSP055741A (no)
ES (1) ES2478620T3 (no)
FR (1) FR2844795B1 (no)
GE (1) GEP20074215B (no)
HK (1) HK1065791A1 (no)
HR (1) HRP20050359B1 (no)
IL (1) IL167316A (no)
IS (1) IS7807A (no)
MA (1) MA26102A1 (no)
ME (1) ME00455B (no)
MX (1) MXPA03008643A (no)
MY (1) MY134921A (no)
NO (1) NO328638B1 (no)
NZ (1) NZ528402A (no)
OA (1) OA12934A (no)
PL (1) PL214400B1 (no)
PT (1) PT1403266E (no)
RS (2) RS20050240A (no)
SG (1) SG110071A1 (no)
SI (1) SI1403266T1 (no)
TN (1) TNSN05087A1 (no)
UA (1) UA79156C2 (no)
WO (1) WO2004029036A1 (no)
ZA (1) ZA200307409B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1534305T3 (pl) * 2003-05-07 2007-03-30 Osteologix As Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie
PL2266584T3 (pl) * 2003-05-07 2013-02-28 Osteologix As Kompozycja ze strontem i witaminą D do profilaktyki i/lub leczenia chorób chrząstki i/lub kości
AU2005216596B2 (en) * 2004-02-26 2011-03-24 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
EP1744770A2 (en) * 2004-05-06 2007-01-24 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
ATE443541T1 (de) 2004-06-25 2009-10-15 Strontin Aps Zusammensetzungen mit strontium und vitamin d und ihre verwendungen
FR2875807B1 (fr) 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100538672C (zh) * 2005-04-18 2009-09-09 索尼株式会社 控制设备和方法
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
WO2007020527A2 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2921367B1 (fr) 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
US9301945B2 (en) 2011-07-21 2016-04-05 Emory University Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102321068B (zh) * 2011-08-01 2013-01-23 山东铂源药业有限公司 一种雷奈酸锶的制备方法
WO2013175270A1 (en) * 2012-05-25 2013-11-28 Fleming Laboratories Limited Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
ES2505716T3 (es) 2013-01-21 2015-09-04 Galenicum Health S.L. Composiciones farmacéuticas que comprenden una sal de ácido
CN103319454B (zh) * 2013-06-14 2014-06-18 广东众生药业股份有限公司 一种高纯度雷尼酸四乙酯及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates

Also Published As

Publication number Publication date
KR20040026625A (ko) 2004-03-31
SI1403266T1 (sl) 2014-06-30
EA200300925A1 (ru) 2004-04-29
MA26102A1 (fr) 2004-04-01
NZ528402A (en) 2004-07-30
HRP20050359B1 (hr) 2014-09-26
ES2478620T3 (es) 2014-07-22
EP1403266A1 (fr) 2004-03-31
GEP20074215B (en) 2007-10-10
IL167316A (en) 2008-08-07
JP2004149516A (ja) 2004-05-27
AU2003282179A1 (en) 2004-04-19
ECSP055741A (es) 2005-07-06
AR041355A1 (es) 2005-05-11
AP2005003256A0 (en) 2005-03-31
RS20050240A (en) 2007-06-04
US20040063972A1 (en) 2004-04-01
CA2442878C (fr) 2009-03-03
CN1212321C (zh) 2005-07-27
AP1910A (en) 2008-10-30
DK1403266T3 (da) 2014-07-07
UA79156C2 (en) 2007-05-25
NO328638B1 (no) 2010-04-12
ME00455B (me) 2011-10-10
BR0304213A (pt) 2004-08-31
EA007489B1 (ru) 2006-10-27
TNSN05087A1 (fr) 2007-05-14
MY134921A (en) 2008-01-31
IS7807A (is) 2005-04-19
EP1403266B1 (fr) 2014-04-09
HK1065791A1 (en) 2005-03-04
US7214805B2 (en) 2007-05-08
ZA200307409B (en) 2004-07-07
CY1115162T1 (el) 2016-12-14
AU2003248281B2 (en) 2009-08-06
FR2844795A1 (fr) 2004-03-26
WO2004029036A1 (fr) 2004-04-08
JP4136867B2 (ja) 2008-08-20
PL362365A1 (en) 2004-04-05
SG110071A1 (en) 2005-04-28
KR100551501B1 (ko) 2006-02-13
FR2844795B1 (fr) 2004-10-22
PL214400B1 (pl) 2013-07-31
RS53509B1 (en) 2015-02-27
MXPA03008643A (es) 2005-04-19
CN1496986A (zh) 2004-05-19
OA12934A (en) 2006-10-13
HRP20050359A2 (en) 2005-06-30
CA2442878A1 (fr) 2004-03-24
AU2003248281A1 (en) 2004-04-08
PT1403266E (pt) 2014-05-06
NO20034235L (no) 2004-03-25
CR7764A (es) 2005-10-06

Similar Documents

Publication Publication Date Title
NO20034235L (no) Ny fremgangsmate for den industrielle syntese av strontiumranelat og dets hydrater
NO20044148L (no) Sammensetning og fremgangsmate for bronnrensing
NO20034964D0 (no) Sementsammensetning egnet for olje- og gassbrönner
ATE333463T1 (de) Selektive dipeptidische inhibitoren von kallikrein
NO20030265D0 (no) Fremgangsmåter ved behandling av borebrönner
EP1558341A4 (en) TRANSCRIPTION FACTOR MODULATING CONNECTIONS AND THEIR USE
NO20013061D0 (no) Kombinert tetnings og gripeenhet for opphentbare pakninger
ATE357432T1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
IS7600A (is) Aðferð til að stuðla að reykbindindi
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
SE0303102L (sv) Realtidsanalys av gasblandningar
ATE290530T1 (de) Kristalline hydrate von anilid-derivaten als funigizide und insektizide
DE602004031527D1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
AU2003275056A8 (en) Novel lapacho compounds and methods of use thereof
NO20034237D0 (no) Ny fremgangsmåte for den industrielle syntese av metyldiesteren av 5-amino-3-karboksymetyl-4-cyano-2-tiofenkarboksylsyre, og anvendelse isyntesen av bivalente salter av ranelinsyre og deres hydrater
NO20034531D0 (no) Brönnbetjeningsfluid og fremgangsmåte for fremstilling og anvendelse av dette
DE60331820D1 (de) Beseitigung von verstopfungen von rohrleitungen
AU2003241335A8 (en) Method of analyzing ataxia-telangiectasia protein
NO20020620D0 (no) Lyddemper og fremgangsmåte for tildannelse av samme
FI20020775A (fi) Menetelmä komponenttien poistamiseksi öljystä, parannettu öljytuote ja sen käyttö
AU2003267944A8 (en) Novel trifluoromethylepinephrine compounds and methods of making and using thereof
FI6126U1 (fi) Avoimen rakentamisen tehokas toteuttaminen
FI20020236A0 (fi) Menetelmä ja laite, jolla estetään otsonikaasun muodostumista
NO20023330D0 (no) Fremgangsmåte og mellomprodukter for fremstilling av sykloheksylnitril
FI20021941A0 (fi) Avoimen rakentamisen tehokkaampi toteuttaminen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees